Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region

Cellular and Molecular Life Sciences

Volumn 59, Issue 1, 2002, Pages 171-180

  Rothenberger, S ^a   Rousseaux, M ^a   Knecht, H ^b   Bender, F C ^a   Legler, D F ^a   Bron, C ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

Lipid rafts; LMP1; TRAF2; TRAF3

Indexed keywords

LATENT MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MORPHOLOGY; NONHUMAN; PROTEIN LOCALIZATION;

CELL LINE; CELL MEMBRANE; GENES, DOMINANT; HUMANS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; NF-KAPPA B; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEINS; SEQUENCE DELETION; SOLUBILITY; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 0036159169     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8413-y     Document Type: Article

References (50)

1. Epstein-Barr virus
2. The role of Epstein-Barr virus in neoplastic transformation
3. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
4. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus
5. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers
6. Epstein-Barr virus: LMP1 masquerades as an active receptor
7. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
8. Epstein-Barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-kappaB
9. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
10. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
11. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity
12. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs
13. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
14. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta
15. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3
16. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation
17. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation
18. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
19. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
20. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells
21. Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells
22. Lipid rafts and signal transduction
23. Microdomains in lymphocyte signalling: Beyond GPI-anchored proteins
24. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation
25. Antigen decoding by T lymphocytes: From synapses to fate determination
26. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling
27. CD40 signaling in human dendritic cells is initiated within membrane rafts
28. Measles virus structural components are enriched into lipid raft microdomains: A potential cellular location for virus assembly
29. Influenza viruses select ordered lipid domains during budding from the plasma membrane
30. The Nef protein of HIV-1 associates with rafts and primes T cells for activation
31. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain
32. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
33. Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association
34. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription
35. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
36. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells
37. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease
38. Functions of lipid rafts in biological membranes
39. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus
40. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein
41. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation
42. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity
43. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts
44. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors
45. Membrane localization of TRAF 3 enables JNK activation
46. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains
47. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex
48. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue
49. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity
50. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation